Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer

By sjmartinez • April 30, 2024

Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May;13(9):e7212. doi: 10.1002/cam4.7212. PMID: 38686626; PMCID: PMC11058674.

Tags: APG‐157, Digestive Diseases, Head and neck cancer, Hematology/Oncology, immune checkpoint inhibitors, microbiome, Publications, tumor microenvironment, Veterans Administration

Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander lung cancer survivors: a SEER-Medicare analysis

Zhang YF, Chang CE, Varghese TK Jr, Tao R, Hashibe M. Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander[...]

Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook

Chowdhury K, Das D, Huang M. Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook. Genes (Basel). 2025 Mar 12;16(3):334. doi: 10.3390/genes16030334. PMID:[...]

Observational, causal relationship and shared genetic basis between cholelithiasis and gastroesophageal reflux disease: evidence from a cohort study and comprehensive genetic analysis

Lyu Y, Tong S, Huang W, Ma Y, Zeng R, Jiang R, Luo R, Leung FW, Lian Q, Sha W, Chen H. Observational, causal relationship[...]